Trial Profile
The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Advanced Glycation End Products
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Empagliflozin (Primary) ; Linagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 13 Feb 2018 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 15 May 2017 Planned initiation date changed from 1 Jul 2017 to 1 Dec 2017.
- 08 Dec 2016 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.